AN2 Therapeutics, Inc.
Industry: Life Sciences ・ $ANTX on Nasdaq
Insider Sale
+$1,652,427
-3.42%
Shares
Shares Volume: 84,093 Shares
Average Share Price: $19.65
INSIDER
Adjuvant Global Health Technology Fund, L.P.
10% Owner
reported on Jan 18 2024
traded on Jan 16 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 2,373,500 |
| PURCHASES/SALES 1Y | 0 / 14 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $283,381.31 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 4 |
| PURCHASES/SALES 1Y | 2 / 33 |
| P/S VALUE RATIO | 2.533 |
| AVERAGE SALE VALUE | $192,080.35 |
| COMPANY PREVIOUS TRADES |